C

Director, Medical Science Liaison, North Central US

Celcuity
Full-time
On-site
hybrid
$230,000 - $256,000 USD yearly
Medical Affairs
Our advice- run this job description AND your resume through AI- and see what the Employer's ATS will flag and evaluate if you are a match.
If you're aiming for a job like this, you need an edge.

Our JobsAI tool gives you that edge—by helping you upgrade your resume, analyze hiring managers’ LinkedIn profiles, and prepare with a built-in interview coach.

Get a FREE trial and see for yourself!

👉 Check out JobsAI

Director, Medical Science Liaison

Location

North Central (Minnesota, Iowa, Nebraska, South Dakota, North Dakota, Kansas, Missouri)

Position Summary

We are seeking a Director, MSL who will report to the Senior Director, Western US Field Medical. The Director, MSL will be responsible for scientific exchange with Health Care Providers (HCPs) and key decision makers (managed care, payers, formulary committees, etc.) on Celcuity’s products, relevant disease states, and in support of clinical trials.

MSL’s combine a strong business acumen, disease state knowledge, clinical knowledge/experience, market awareness, and serve as a conduit for Celcuity’s scientific data to external customers while providing external market and clinical insights internally to cross-functional teams. Travel within the territory and the US for medical conferences will be expected.

Responsibilities

  • Identify and cultivate professional relationships KOLs in designated tumor types.
  • Maintain cross-functional field partnerships allowing for appropriate collaboration with field commercial teams (sales, market access, etc.), and Clinical Development associates.
  • Maintain and develop synergistic relationships with KOLs to expand research, advisory, and educational partnership opportunities.
  • Assist the Clinical Development Team in the identification and education of potential clinical trial sites, assist, upon request, in troubleshooting issues during clinical trial conduct.
  • Develop scientific expertise on all Celcuity’s products, related disease states, and the clinical practice for a given therapeutic area.
  • Communicate scientific content, written and verbal, related to Celcuity’s products and related disease states.
  • Be knowledgeable of and follow all applicable laws, SOPs and guidance documents ensuring compliance.
  • Provide scientific training to internal colleagues.
  • Participate in the Medical, Legal, and Regulatory review process, as needed, in the role of scientific expert.
  • Identify, categorize, and communicate key clinical insights related to assigned disease state and products.
  • Other duties as assigned.

Qualifications

  • MD, PharmD, or PhD in Life Sciences, D.Sc., D.N.P, or D.O. degree.
  • Solid tumor oncology experience.
  • Excellent presentation and communication skills.
  • Conveying complex scientific concepts and information appropriately tailored to the audience (internal staff, physicians, nurses, patient advocacy groups, formulary committees, etc.).
  • 3+ years of related pharmaceutical Medical Science Liaison experience.
  • Breast Cancer experience.
  • Knowledge of clinical research design and GCP in the oncology area.
  • Experiences at small/start-up biopharmaceutical company.
  • Strong business acumen.
  • Experience with payor groups, market access teams, formulary committees, and treatment guidelines.
  • Experience managing territory resources and budgets. Demonstrated self-starter.
  • Experience launching products.

About Us

Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth.

Our lead therapeutic candidate, gedatolisib, is an intravenously administered, potential first-in-class PI3K/AKT/mTOR (PAM) pathway inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings. A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is on-going.

Celcuity Is An Equal-Opportunity Employer

Celcuity is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are competitive. For this role, the anticipated base pay range is $230,000 - $256,000. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.

The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package. Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.

Notice To Recruiters/Staffing Agencies

Recruiters and staffing agencies should not contact Celcuity through this page. All recruitment vendors (search firms, recruitment agencies, and staffing companies) are prohibited from contacting our hiring manager(s), executive team members, or employees directly.

We require that all recruiters and staffing agencies have a fully executed, formal written agreement on file. Celcuity’s receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Celcuity and such organization and will be considered unsolicited. Celcuity will not be responsible for related fees.